CH639076A5 - Process for the preparation of 4-oxoimidazolidine compounds - Google Patents
Process for the preparation of 4-oxoimidazolidine compounds Download PDFInfo
- Publication number
- CH639076A5 CH639076A5 CH1554577A CH1554577A CH639076A5 CH 639076 A5 CH639076 A5 CH 639076A5 CH 1554577 A CH1554577 A CH 1554577A CH 1554577 A CH1554577 A CH 1554577A CH 639076 A5 CH639076 A5 CH 639076A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- compound
- alkyl
- phenyl
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
- C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
- C07C273/1827—X being H
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB52955/76A GB1598662A (en) | 1976-12-18 | 1976-12-18 | 10,12-diazoprostaglandins |
| GB3036977 | 1977-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH639076A5 true CH639076A5 (en) | 1983-10-31 |
Family
ID=26260409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1554577A CH639076A5 (en) | 1976-12-18 | 1977-12-16 | Process for the preparation of 4-oxoimidazolidine compounds |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5382779A (xx) |
| AT (1) | AT368498B (xx) |
| AU (1) | AU514523B2 (xx) |
| CH (1) | CH639076A5 (xx) |
| DE (1) | DE2755771A1 (xx) |
| DK (1) | DK551777A (xx) |
| ES (1) | ES465176A1 (xx) |
| FI (1) | FI773812A (xx) |
| FR (1) | FR2374309A1 (xx) |
| IL (1) | IL53559A0 (xx) |
| NL (1) | NL7713971A (xx) |
| NO (1) | NO774348L (xx) |
| NZ (1) | NZ185909A (xx) |
| PH (1) | PH14398A (xx) |
| SE (1) | SE7714373L (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
| AU531493B2 (en) * | 1977-12-01 | 1983-08-25 | The Wellcome Foundation Limited | Thiohydantion derivatives |
| EP0003410B1 (en) * | 1978-01-23 | 1982-10-06 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
| EP0004723A1 (en) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them |
| AU4806979A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | 1,2,4 triazole derivatives |
| EP0006352A1 (en) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them |
| IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
| AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
| EP0019223A1 (en) * | 1979-05-09 | 1980-11-26 | The Wellcome Foundation Limited | Optically active hydantoin derivatives, their synthesis, pharmaceutical formulations containing them, and intermediates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2323193A1 (de) | 1972-05-10 | 1973-11-22 | Du Pont | Pyrazolidinone |
| FR2258376A1 (en) | 1974-01-21 | 1975-08-18 | Aries Robert | 10-Aza prostaglandins - for treatment of blood pressure and gastro-intestinal disorders and in prepn for confinement |
| GB1524818A (en) | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-12-07 IL IL53559A patent/IL53559A0/xx unknown
- 1977-12-08 NZ NZ185909A patent/NZ185909A/xx unknown
- 1977-12-09 DK DK551777A patent/DK551777A/da not_active Application Discontinuation
- 1977-12-14 DE DE19772755771 patent/DE2755771A1/de not_active Withdrawn
- 1977-12-14 AT AT0893777A patent/AT368498B/de not_active IP Right Cessation
- 1977-12-15 AU AU31613/77A patent/AU514523B2/en not_active Expired
- 1977-12-16 CH CH1554577A patent/CH639076A5/de not_active IP Right Cessation
- 1977-12-16 SE SE7714373A patent/SE7714373L/xx not_active Application Discontinuation
- 1977-12-16 NO NO774348A patent/NO774348L/no unknown
- 1977-12-16 FR FR7738009A patent/FR2374309A1/fr active Granted
- 1977-12-16 FI FI773812A patent/FI773812A/fi not_active Application Discontinuation
- 1977-12-16 ES ES465176A patent/ES465176A1/es not_active Expired
- 1977-12-16 NL NL7713971A patent/NL7713971A/xx not_active Application Discontinuation
- 1977-12-19 JP JP15279377A patent/JPS5382779A/ja active Pending
- 1977-12-19 PH PH20569A patent/PH14398A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2374309A1 (fr) | 1978-07-13 |
| ATA893777A (de) | 1982-02-15 |
| IL53559A0 (en) | 1978-03-10 |
| NL7713971A (nl) | 1978-06-20 |
| FR2374309B1 (xx) | 1980-05-16 |
| JPS5382779A (en) | 1978-07-21 |
| NO774348L (no) | 1978-06-20 |
| PH14398A (en) | 1981-06-25 |
| DE2755771A1 (de) | 1978-06-29 |
| ES465176A1 (es) | 1979-01-01 |
| NZ185909A (en) | 1980-11-14 |
| AU514523B2 (en) | 1981-02-12 |
| DK551777A (da) | 1978-06-19 |
| AU3161377A (en) | 1979-06-21 |
| AT368498B (de) | 1982-10-11 |
| FI773812A (fi) | 1978-06-19 |
| SE7714373L (sv) | 1978-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2516025C2 (xx) | ||
| DD216929A5 (de) | Verfahren zur herstellung von thiazolidinderivaten | |
| DE2317019A1 (de) | Neue 4,5-didehydro-prostaglandine | |
| CH646426A5 (en) | Process for the preparation of hydantoin derivatives | |
| CH639076A5 (en) | Process for the preparation of 4-oxoimidazolidine compounds | |
| DE3240727A1 (de) | Ergolinderivate, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten | |
| DE2739277C2 (de) | Prostaglandinderivate, Verfahren zu deren Herstellung und deren Verwendung | |
| DE2737808A1 (de) | 2-substituierte aryl-heterocyclische omega-pentanorprostaglandine | |
| CH637646A5 (de) | Analgetisch wirksame triazindione, herstellungsverfahren und pharmazeutische zusammensetzungen. | |
| DE2346706A1 (de) | Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung | |
| DE2647969A1 (de) | Cyclische amide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| EP0027928B1 (de) | Piperidinderivate von 4,5-Dialkyl-3-hydroxy-pyrrol-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DE3116414C2 (xx) | ||
| DE2314335A1 (de) | Neue amide der apovincaminsaeure, deren salze, herstellung und medikamente, die diese enthalten | |
| DE2427272C3 (de) | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum | |
| DE2945781A1 (de) | Prostacyclinzwischenprodukte und protacyclinanaloge | |
| CH636347A5 (en) | Process for preparing 5,9-cyclic ethers of 9-deoxy-prostaglandin-F(1 alpha)-type compounds | |
| EP0030343A1 (de) | Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE2737807A1 (de) | C tief 1 -p-biphenylester von omega-pentanorprostaglandinen | |
| EP0073997A1 (de) | Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| CH638190A5 (de) | Verfahren zur herstellung von derivaten des 1,2,4-triazolidin-2,5-dions. | |
| EP0030688B1 (de) | Piperidinderivate von 3-Hydroxy-thiophen-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DE2629756C2 (xx) | ||
| DE2647968A1 (de) | Methylsubstituierte cyclische amide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| DE2822473C2 (de) | Alkanolaminderivate und pharmazeutische Mittel, welche diese Alkanolaminderivate enthalten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |